Drug Type AAV based gene therapy |
Synonyms rAAV.sFlt-1, AVA-101(Adverum) |
Target |
Mechanism VEGFR1 modulators(Vascular endothelial growth factor receptor 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinal Neovascularization | Phase 2 | AU | 01 Dec 2011 | |
Wet age-related macular degeneration | Phase 2 | AU | 01 Dec 2011 |